These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21585196)

  • 1. Targeted cleavage of HIV RRE RNA by Rev-coupled transition metal chelates.
    Joyner JC; Cowan JA
    J Am Chem Soc; 2011 Jun; 133(25):9912-22. PubMed ID: 21585196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA nuclease activity of Rev-coupled transition metal chelates.
    Joyner JC; Keuper KD; Cowan JA
    Dalton Trans; 2012 Jun; 41(21):6567-78. PubMed ID: 22450234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted catalytic inactivation of angiotensin converting enzyme by lisinopril-coupled transition-metal chelates.
    Joyner JC; Hocharoen L; Cowan JA
    J Am Chem Soc; 2012 Feb; 134(7):3396-410. PubMed ID: 22200082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics and Mechanisms of Oxidative Cleavage of HIV RRE RNA by Rev-Coupled Transition Metal Chelates.
    Joyner JC; Keuper KD; Cowan JA
    Chem Sci; 2013 Apr; 4(4):1707-1718. PubMed ID: 23626900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the DNA nuclease activity of iron, cobalt, nickel, and copper chelates.
    Joyner JC; Reichfield J; Cowan JA
    J Am Chem Soc; 2011 Oct; 133(39):15613-26. PubMed ID: 21815680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy.
    Lacourciere KA; Stivers JT; Marino JP
    Biochemistry; 2000 May; 39(19):5630-41. PubMed ID: 10801313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1.
    DeJong ES; Chang CE; Gilson MK; Marino JP
    Biochemistry; 2003 Jul; 42(26):8035-46. PubMed ID: 12834355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS; Petrovic A; Jeong KS; Venkatesan S
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structures and characterization of human immunodeficiency virus Rev responsive element IIB RNA targeting zinc finger proteins.
    Mishra SH; Shelley CM; Barrow DJ; Darby MK; Germann MW
    Biopolymers; 2006 Nov; 83(4):352-64. PubMed ID: 16826557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of peptides with nucleobase amino acids: design and synthesis of the nucleobase-conjugated peptides derived from HIV-1 Rev and their binding properties to HIV-1 RRE RNA.
    Takahashi T; Hamasaki K; Ueno A; Mihara H
    Bioorg Med Chem; 2001 Apr; 9(4):991-1000. PubMed ID: 11354682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric inhibition of the HIV-1 Rev/RRE interaction by a 3'-methylphosphonate modified antisense oligo-2'-O-methylribonucleotide.
    Prater CE; Saleh AD; Wear MP; Miller PS
    Oligonucleotides; 2007; 17(3):275-90. PubMed ID: 17854268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV Rev response element (RRE) directs assembly of the Rev homooligomer into discrete asymmetric complexes.
    Daugherty MD; Booth DS; Jayaraman B; Cheng Y; Frankel AD
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12481-6. PubMed ID: 20616058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
    Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
    Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted cleavage of HIV rev response element RNA by metallopeptide complexes.
    Jin Y; Cowan JA
    J Am Chem Soc; 2006 Jan; 128(2):410-1. PubMed ID: 16402818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.
    Litovchick A; Rando RR
    RNA; 2003 Aug; 9(8):937-48. PubMed ID: 12869705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric RNase H-competent oligonucleotides directed to the HIV-1 Rev response element.
    Prater CE; Saleh AD; Wear MP; Miller PS
    Bioorg Med Chem; 2007 Aug; 15(16):5386-95. PubMed ID: 17566743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.